Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Amortizatization of Intangibles: 2015-2024

Historic Amortizatization of Intangibles for Cidara Therapeutics (CDTX) over the last 6 years, with Dec 2024 value amounting to $79,000.

  • Cidara Therapeutics' Amortizatization of Intangibles rose 665.00% to $153,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $205,000, marking a year-over-year increase of 210.61%. This contributed to the annual value of $79,000 for FY2024, which is 1216.67% up from last year.
  • According to the latest figures from FY2024, Cidara Therapeutics' Amortizatization of Intangibles is $79,000, which was up 1,216.67% from $6,000 recorded in FY2023.
  • In the past 5 years, Cidara Therapeutics' Amortizatization of Intangibles ranged from a high of $79,000 in FY2024 and a low of $6,000 during FY2023.
  • For the 2-year period, Cidara Therapeutics' Amortizatization of Intangibles averaged around $42,500, with its median value being $42,500 (2023).
  • Data for Cidara Therapeutics' Amortizatization of Intangibles shows a peak YoY skyrocketed of 1,216.67% (in 2024) over the last 5 years.
  • Cidara Therapeutics' Amortizatization of Intangibles (Yearly) stood at $6,000 in 2023, then spiked by 1,216.67% to $79,000 in 2024.